Editas Medicine Inc. logo

Editas Medicine Inc. (EDIT)

Market Open
16 Oct, 04:47 PM
NASDAQ (NGS) NASDAQ (NGS)
$
2. 35
-0.08
-3.4836%
$
374.74M Market Cap
- P/E Ratio
- Div Yield
644,896 Volume
-2.37 Eps
$ 2.44
Previous Close
Add Transaction
Day Range
2.33 2.44
Year Range
1.66 4.28
Want to track EDIT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Editas Medicine Inc. (EDIT) Statistics

Valuation metrics

Market Cap 374.74M
Enterprise value 278.74M
Trailing P/E (ttm) -3.88
Forward P/E -3.05
PEG ratio -0.02
Price/Sales (ttm) 9.47
Price/Book (mrq) 3.29
Enterprise Value/Revenue 5.93
Enterprise Value/EBITDA -3.97

Overview

Shares outstanding 97.9M
Float 97.64M
Shares short 10.01M
% Held by insiders 0%
% Held by institutions 0.55%
Average volume (10 days) 2.36M
Average volume (90 days) 2.08M

Price summary

52-Week low 1.66
52-Week high 4.28
Beta 2.14
50-Day moving average 2.73
200-Day moving average 2.85

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -1.57%
Operating margin -1.75%

Operational effectiveness

Return on assets -0.31%
Return on equity -1.97%

Income Statement

Revenue (ttm) 38.69M
Revenue per share (ttm) 0.39
Quarterly revenue growth (yoy) -0.39%
Gross profit (ttm) -42.27M
EBITDA -85.19M
Net income to common (ttm) -108.95M
Diluted EPS (ttm) -0.62
Quarterly earnings growth (yoy) -0.39%

Balance Sheet

Total cash (mrq) 123.65M
Total cash per share (mrq) 1.77
Total debt (mrq) 17.3M
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 3.19%
Book value per share (mrq) 0.88

Cash Flow

Cash flow statement -140.5M
Levered free cash flow (LFCF) -73.82M